is phentermine a glp 1 receptor agonist GLP-1 agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal GLP-1 Agonists: A Comprehensive Overview

PMID: 30529260

Cyclic peptide-based nanostructures as efficient siRNA carriers

To enhance the therapeutic efficacy of resveratrol, we investigated the protective effects of liposomal resveratrol (LR) in a streptozotocin-induced diabetic rat model at doses of 20 and 40 mg/kg

Zhang Y, Xie L, Ding X, Wang Y, Xu Y, Li D, et al

Lipids of the sperm plasma membrane: from polyunsaturated fatty acids considered as markers of sperm function to possible scavenger therapy

While research is still ongoing, there is some evidence to suggest that BPC-157 may have neuroprotective effects and could potentially be used in the treatment of traumatic brain injury